Santarus and the University of Missouri accused the generic drugmaker Par Pharmaceutical of infringing five U.S. patents for the heartburn medicine Zegerid as a nonjury trial began in federal court. Santarus, a San Diego-based company that licenses the patents from ...
Tagged with: Par Pharmaceutical patent infringement Santarus University of Missouri Zegerid
Read More »